Findings from a study recently announced that a steroid drug can now be used to treat multiple sclerosis (MS) in addition to the usually prescribed MS drugs. This finding was part of the Late-breaking Science Program at the American Academy of Neurology’s 61st Annual Meeting in Seattle, held in April 25 – May 2, 2009.

In the study, 341 people with relapsing-remitting multiple sclerosis (MS) participated. Half of the participants were given both steroid drug methylprednisolone, plus the regular weekly treatment with the drug interferon beta-1a. Meanwhile, the other 50% of the participants were administered with the interferon drug plus a placebo. The participants who were administered with both drugs had 38 percent fewer relapses than those who were only given interferon drug.

These results showed that interfon work only moderate and not everyone responds fully to the treatment, but when combined with steroid drug methylprednisolone, more beneficial effects of controlling multiple sclerosis attacks.

Comments

comments

Tags: interfon, methylprednisolone, MS, multiple sclerosis, steroid drug

Posted in Steroid Cycles, steroid nation, Steroids and Anabolic Steroids